Page last updated: 2024-11-04

talipexole and Tourette Syndrome

talipexole has been researched along with Tourette Syndrome in 1 studies

talipexole: dopamine receptor agonist; structure given in first source

Tourette Syndrome: A neuropsychological disorder related to alterations in DOPAMINE metabolism and neurotransmission involving frontal-subcortical neuronal circuits. Both multiple motor and one or more vocal tics need to be present with TICS occurring many times a day, nearly daily, over a period of more than one year. The onset is before age 18 and the disturbance is not due to direct physiological effects of a substance or another medical condition. The disturbance causes marked distress or significant impairment in social, occupational, or other important areas of functioning. (From DSM-IV, 1994; Neurol Clin 1997 May;15(2):357-79)

Research Excerpts

ExcerptRelevanceReference
"Talipexole is a new dopamine autoagonist with putative preferential activity on presynaptic dopamine receptors."2.67Talipexole and adult Gilles de la Tourette's syndrome: double-blind, placebo-controlled clinical trial. ( Goetz, CG; Stebbins, GT; Thelen, JA, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goetz, CG1
Stebbins, GT1
Thelen, JA1

Trials

1 trial available for talipexole and Tourette Syndrome

ArticleYear
Talipexole and adult Gilles de la Tourette's syndrome: double-blind, placebo-controlled clinical trial.
    Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:3

    Topics: Adult; Azepines; Dopamine Agents; Double-Blind Method; Humans; Male; Middle Aged; Neurologic Examina

1994